Jeanne Chiaravalli

ORCID: 0000-0001-9135-4565
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Peptidase Inhibition and Analysis
  • SARS-CoV-2 and COVID-19 Research
  • Radiopharmaceutical Chemistry and Applications
  • Semiconductor materials and devices
  • vaccines and immunoinformatics approaches
  • NF-κB Signaling Pathways
  • Computational Drug Discovery Methods
  • COVID-19 Clinical Research Studies
  • Click Chemistry and Applications
  • interferon and immune responses
  • SARS-CoV-2 detection and testing
  • CRISPR and Genetic Engineering
  • Medical Imaging and Pathology Studies
  • Synthesis and biological activity
  • Bacillus and Francisella bacterial research
  • Amyotrophic Lateral Sclerosis Research
  • Pharmacological Effects of Natural Compounds
  • Ferrocene Chemistry and Applications
  • RNA regulation and disease
  • Hippo pathway signaling and YAP/TAZ
  • Complement system in diseases
  • Immune Response and Inflammation
  • Developmental Biology and Gene Regulation
  • Wnt/β-catenin signaling in development and cancer
  • Ubiquitin and proteasome pathways

Institut Pasteur
2004-2025

Centre National de la Recherche Scientifique
2004-2024

Université Paris Cité
2021-2024

Rockefeller University
2014-2021

High Throughput Biology (United States)
2020-2021

Abstract Hippo signaling is an evolutionarily conserved pathway that restricts growth and regeneration predominantly by suppressing the activity of transcriptional coactivator Yap. Using a high-throughput phenotypic screen, we identified potent non-toxic activator In vitro kinase assays show compound acts as ATP-competitive inhibitor Lats kinases—the core enzymes in signaling. The substance prevents Yap phosphorylation induces proliferation supporting cells murine inner ear, cardiomyocytes,...

10.1038/s41467-021-23395-3 article EN cc-by Nature Communications 2021-05-25

Abstract SARS-CoV-2 is continually evolving, with more contagious mutations spreading rapidly. Using in vitro evolution to affinity maturate the receptor-binding domain (RBD) of spike protein towards ACE2 resulted mutations, S477N, E484K, and N501Y, be among first selected, explaining convergent “European” (20E-EU1), “British” (501.V1),”South African” (501.V2), ‘‘Brazilian” variants (501.V3). Plotting binding all RBD against their incidence population shows a strong correlation between two....

10.1101/2021.01.06.425392 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2021-01-06

Abstract SARS-CoV-2 is the causative agent behind COVID-19 pandemic, responsible for over 170 million infections, and 3.7 deaths worldwide. Efforts to test, treat vaccinate against this pathogen all benefit from an improved understanding of basic biology SARS-CoV-2. Both viral cellular proteases play a crucial role in replication. Here, we study proteolytic cleavage proteins two cell line models replication using mass spectrometry identify protein neo-N-termini generated through protease...

10.1038/s41467-021-25796-w article EN cc-by Nature Communications 2021-09-21
Cyril Planchais I. Fernández Timothée Bruel Guilherme Dias de Melo Matthieu Prot and 95 more Maxime Beretta Pablo Guardado‐Calvo Jérémy Dufloo Luis M. Molinos‐Albert Marija Backović Jeanne Chiaravalli Émilie Giraud Benjamin Vesin Laurine Conquet Ludivine Grzelak Delphine Planas Isabelle Staropoli Florence Guivel‐Benhassine Thierry Hieu Mikaël Boullé Minerva Cervantes-Gonzalez Marie‐Noëlle Ungeheuer Pierre Charneau Sylvie van der Werf Fabrice Agou Marie Bartoli Alpha Diallo Soizic Le Mestre Christelle Paul Ventzislava Petrov–Sanchez Yazdan Yazdanpanah C. Ficko Catherine Chirouze Claire Andréjak Denis Malvy François Goehringer Patrick Rossignol Tristan Gigante Morgane Gilg Bénédicte Rossignol Manuel Etienne Marine Beluze Delphine Bachelet Krishna Bhavsar Lila Bouadma Minerva Cervantes-Gonzalez Anissa Chair Charlotte Charpentier Léo Chenard Camille Couffignal Marie‐Pierre Debray Diane Descamps Xavier Duval Philippine Eloy Marina Esposito‐Farèse Aline-Marie Florence Jade Ghosn Isabelle Hoffmann Ouifiya Kafif Antoine Khalil Nadhem Lafhej Cédric Laouénan Samira Laribi Minh Quan Lê Quentin Le Hingrat Sophie Letrou France Mentré Gilles Peytavin Valentine Piquard Carine Roy Marion Schneider Helen C. Su Coralie Tardivon Jean‐François Timsit Sarah Tubiana Benoît Visseaux Dominique Deplanque Jean‐Sébastien Hulot Jean‐Luc Diehl Olivier Picone François Angoulvant Amal Abrous Sandrine Couffin-Cadièrgues Fernanda Dias Da Silva Hélène Esperou Ikram Houas Salma Jaafoura Aurélie Papadopoulos Alexandre Gaymard Bruno Lina Manuel Rosa‐Calatrava Céline Dorival Jérémie Guedj Guillaume Lingas Nadège Néant Laurent Abel Victoria Manda Sylvie Behillil Vincent Enouf Yves Lévy

Memory B-cell and antibody responses to the SARS-CoV-2 spike protein contribute long-term immune protection against severe COVID-19, which can also be prevented by antibody-based interventions. Here, wide immunoprofiling in Wuhan COVID-19 convalescents combining serological, cellular, monoclonal explorations revealed humoral immunity coordination. Detailed characterization of a hundred memory antibodies uncovered diversity their repertoire antiviral functions. The latter were influenced...

10.1084/jem.20220638 article EN cc-by-nc-sa The Journal of Experimental Medicine 2022-06-15

The landscape of SARS-CoV-2 variants dramatically diversified with the simultaneous appearance multiple subvariants originating from BA.2, BA.4, and BA.5 Omicron sub-lineages. They harbor a specific set mutations in spike that can make them more evasive to therapeutic monoclonal antibodies. In this study, we compared neutralizing potential antibodies against BA.2.75.2, BQ.1, BQ.1.1, XBB variants, pre-Omicron Delta variant as reference. Sotrovimab retains some activity it did BA.2/BA.5, but...

10.1016/j.isci.2023.106413 article EN cc-by-nc-nd iScience 2023-03-15

Out of the results sole large-scale screening for inhibitors SARS-CoV-1 main protease reported in 2013, attempts to improve 3-pyridyl-bearing hits found have been conducted research laboratories, either on this enzyme or more recently closely related SARS-CoV-2 protease. From resulting structural information reported, we sought design analogues featuring some components providing an affinity active site these proteases along with a different scaffold which would allow further...

10.1055/a-2519-9876 article EN Synthesis 2025-01-19

Effective drugs against SARS-CoV-2 are urgently needed to treat severe cases of infection and for prophylactic use. The main viral protease (nsp5 or 3CLpro) represents an attractive possibly broad-spectrum target drug development as it is essential the virus life cycle highly conserved among betacoronaviruses. Sensitive efficient high-throughput screening methods key discovery. Here we report a gain-of-signal, sensitive cell-based luciferase assay monitor nsp5 activity show that suitable...

10.1016/j.antiviral.2022.105272 article EN cc-by Antiviral Research 2022-03-09

Most cancer therapies involve a component of treatment that inflicts DNA damage in tumor cells, such as double-strand breaks (DSBs), which are considered the most serious threat to genomic integrity. Complex systems have evolved repair these lesions, and successful DSB is essential for cell survival after exposure ionizing radiation (IR) other DNA-damaging agents. As such, inhibition potentially efficacious strategy chemo- radiosensitization. Homologous recombination (HR) nonhomologous...

10.1158/1535-7163.mct-14-0765 article EN Molecular Cancer Therapeutics 2014-12-16

NF-kappa B essential modulator/IKK-gamma (NEMO/IKK-gamma) plays a key role in the activation of pathway response to proinflammatory stimuli. Previous studies suggested that signal-dependent IKK complex involves trimerization NEMO. The minimal oligomerization domain this protein consists two coiled-coil subdomains named Coiled-coil 2 (CC2) and leucine zipper (LZ) (Agou, F., Traincard, Vinolo, E., Courtois, G., Yamaoka, S., Israel, A., Veron, M. (2004) J. Biol. Chem. 279, 27861-27869). To...

10.1074/jbc.m406423200 article EN cc-by Journal of Biological Chemistry 2004-10-06

Abstract Memory B-cell and antibody responses to the SARS-CoV-2 spike protein contribute long-term immune protection against severe COVID-19, which can also be prevented by antibody-based interventions. Here, wide immunoprofiling in COVID-19 convalescents combining serological, cellular monoclonal explorations, revealed humoral immunity coordination. Detailed characterization of a hundred memory antibodies uncovered diversity their repertoire antiviral functions. The latter were influenced...

10.1101/2022.04.01.486719 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-04-01

Preventing the misfolding or aggregation of transactive response DNA binding protein with 43 kDa (TDP-43) is most actively pursued disease-modifying strategy to treat amyotrophic lateral sclerosis and other neurodegenerative diseases. In this work, we provide proof concept that native state stabilization TDP-43 a viable effective for treating proteinopathies. Firstly, leveraged Cryo-EM structures fibrils design C-terminal substitutions disrupt aggregation. Secondly, showed these...

10.1002/anie.202314587 article EN Angewandte Chemie International Edition 2023-11-11

The COVID-19 pandemic highlighted the need for antivirals against emerging coronaviruses (CoV). Inhibiting spike (S) glycoprotein-mediated viral entry is a promising strategy. To identify small molecule inhibitors that block downstream of receptor binding, we established high-throughput screening (HTS) platform based on pseudoviruses. We employed three-step process to screen nearly 200,000 molecules. First, identified hits inhibit pseudoviruses bearing SARS-CoV-2 S glycoprotein....

10.1016/j.isci.2024.110019 article EN cc-by-nc-nd iScience 2024-05-17

Abstract Resistance to anti‐microbial agents is a world‐wide health threat. Thus, there an urgent need for new treatments. An alternative approach disarm pathogens consists in developing drugs targeting epigenetic modifiers. Bacterial can manipulate regulatory systems of the host bypass defences proliferate and survive. One example Legionella pneumophila , Gram‐negative intracellular pathogen that targets chromatin with specific, secreted bacterial SET‐domain methyltransferase named RomA....

10.1002/cbic.202400293 article EN ChemBioChem 2024-09-10

Abstract SARS-CoV-2 is the causative agent behind COVID-19 pandemic, and responsible for over 170 million infections, 3.7 deaths worldwide. Efforts to test, treat vaccinate against this pathogen all benefit from an improved understanding of basic biology SARS-CoV-2. Both viral cellular proteases play a crucial role in replication, inhibitors targeting have already shown success at inhibiting cell culture models. Here, we study proteolytic cleavage proteins two line models replication using...

10.1101/2020.09.16.297945 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2020-09-16

We have developed a new high-content cytotoxicity assay using live cells, called "ImageTOX." used high-throughput fluorescence microscope system, image segmentation software, and the combination of Hoechst 33342 SYTO 17 to simultaneously score relative size intensity nuclei, nuclear membrane permeability, cell number in 384-well microplate format. then performed screen 12,668 diverse compounds compared results standard assay. The ImageTOX identified similar sets assay, while identifying more...

10.1177/2472555217724745 article EN cc-by-nc-nd SLAS DISCOVERY 2017-08-07

Summary The landscape of SARS-CoV-2 variants dramatically diversified with the simultaneous appearance multiple sub-variants originating from BA.2, BA.4 and BA.5 Omicron sub-lineages. They harbor a specific set mutations in spike that can make them more evasive to therapeutic monoclonal antibodies. In this study, we compared neutralizing potential antibodies against BA.2.75.2, BQ.1, BQ.1.1 XBB variants, pre-Omicron Delta variant as reference. Sotrovimab retains some activity BQ.1 it did...

10.1101/2022.12.22.521201 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2022-12-23

Abstract Preventing the misfolding or aggregation of transactive response DNA binding protein with 43 kDa (TDP‐43) is most actively pursued disease‐modifying strategy to treat amyotrophic lateral sclerosis and other neurodegenerative diseases. In this work, we provide proof concept that native state stabilization TDP‐43 a viable effective for treating proteinopathies. Firstly, leveraged Cryo‐EM structures fibrils design C‐terminal substitutions disrupt aggregation. Secondly, showed these...

10.1002/ange.202314587 article EN Angewandte Chemie 2023-11-11
Coming Soon ...